Kenneth Rosenzweig

Biography

Dr. Rosenzweig is a pioneer in the development of innovative methods for the delivery of precise doses of radiation to lung tumors during certain points in the respiration cycle, allowing physicians to safely increase the radiation dose, shorten treatment and spare healthy tissue. He has also worked to incorporate positron emission tomography (PET), an imaging procedure that produces advanced biological images of the body, into the radiation treatment.

A groundbreaking researcher in radiation therapy, Dr. Rosenzweig was the principal investigator for a critical-dose escalation study that established the maximum tolerated dose of radiation therapy that can be safely delivered. He has published more than 70 articles in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology Biology Physics and Radiotherapy Oncology. He has authored numerous textbook chapters, including chapters in Principles and Practice of Oncology, the leading textbook of cancer medicine.

In addition to his extensive research background, Dr. Rosenzweig has served on many professional committees, including the Radiation Therapy Oncology Group (RTOG) Lung Committee, the RTOG Data Monitoring Committee and the National Cancer Institute Clinical Trails Evaluation Panel. He has also served as a consultant to the International Atomic Energy Association. An accomplished educator, he was named "Teacher of the Year" by the Association of Residents in Radiation Oncology.

After receiving his medical degree from the Yale University School of Medicine in 1992, Dr. Rosenzweig continued his training as a medical intern at Beth Israel Hospital in Boston and his residency at the Joint Center for Radiation Therapy at Harvard Medical School. He has worked at Memorial Sloan-Kettering Cancer Center since completing his training in 1997.